Synthesis and SAR of a novel Kir6.2/SUR1 channel opener scaffold identified by HTS
- 24 March 2023
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 87, 129256
Abstract
No abstract availableKeywords
Funding Information
- William K Warren Foundation
- Vanderbilt Cancer Center
- National Institutes of Health (S10OD021734)
- Vanderbilt Institute of Chemical Biology, School of Medicine, Vanderbilt University (P30CA68485)
- National Cancer Institute (R50CA211206)
This publication has 13 references indexed in Scilit:
- Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063The Journal of Pharmacology and Experimental Therapeutics, 2019
- Direct Activation of β-Cell KATP Channels with a Novel Xanthine DerivativeMolecular Pharmacology, 2014
- Multiplicity of effectors of the cardioprotective agent, diazoxidePharmacology & Therapeutics, 2013
- Towards Selective Kir6.2/SUR1 Potassium Channel Openers, Medicinal Chemistry and Therapeutic PerspectivesCurrent Medicinal Chemistry, 2006
- The Effects of NN414, a SUR1/Kir6.2 Selective Potassium Channel Opener, in Healthy Male SubjectsThe Journal of Clinical Pharmacology, 2005
- BMS-191095, a cardioselective mitochondrial katp opener, inhibits human platelet aggregation by opening mitochondrial katp channelsArchives of Pharmacal Research, 2005
- KATP channel openers: Structure‐activity relationships and therapeutic potentialMedicinal Research Reviews, 2003
- Potent and selective activation of the pancreatic beta-cell type K ATP channel by two novel diazoxide analoguesDiabetologia, 2003
- Octameric Stoichiometry of the KATP Channel ComplexJournal of General Physiology, 1997
- Hyperpolarizing Vasodilators Activate ATP-sensitive K + Channels in Arterial Smooth MuscleScience, 1989